ʻO nā papa glurenorm - ʻōlelo aʻoaʻo no ka hoʻohana ʻana

Hōʻike
Pākaukau 1 papa:
Mea waiwai: keloliana - 30 mg,
nā mea hoʻowalewale: lactose monohiona, kālai palaoa ʻōpala, soluble starch palaoa, magnesium stearate.

ʻO keʻano
Hoʻokipa, pōʻai, keʻokeʻo me nā beveled kihi o ka papa ʻaina, me kahi kīʻaha ma kekahi ʻaoʻao a me ke kahakaha "57C" ma nā ʻaoʻao ʻelua, pili i nā pilikia, nā kahakaha ʻoihana hui me ka ʻaoʻao o ka ʻaoʻao.

Hoʻolaha hui:

Manaʻo SAX: A10VB08

ʻO nā waiwai Pharmacological
Loaʻa i ko Glurenorm nā hopena pancreatic a me ka extrapancreatic hopena. Hoʻokomo i ka huna huna o ka insulin ma ka hoʻohaʻahaʻa ʻana i ka paepae pancreatic beta-cell glucose irrit, ka hoʻonui ʻana i ka naʻau o ka insulin a me kona hāme ʻana i nā cell target, hoʻonui i ka hopena o ka insulin ma ka ʻāʻī a me ka puʻuwai glucose uptake (hoʻonui i ka nui o nā mea i hoʻokomo i ka insulin i nā kiko kikoʻī), pale i ka lipolysis ma ka kiko adipose. ʻO nā hana i ka lua o ka hana huna o ka insulin, e hōʻemi i nā mea o ka glucagon ma ke koko. Loaʻa iā ia kahi hopena hypolipidemic, e hōʻemi i nā waiwai thrombogenic o ke koko. Hoʻopilikia ka hopena hypoglycemic ma hope o nā hola 1.0-1.5, ka hopena loa - ma hope o nā hola 2-3 a lōʻihi mau hola 12.

Lapaʻau lāʻau
Ke hele wikiwiki nei ʻo Glycvidone a aneane holo i ke kāwili ʻana. Ma hope o ka nānā ʻana i kahi wai hoʻokahi o Glyurenorm (30 mg), ua hōʻea ka nui o ka hōʻemi o ka lāʻau ma ka hope o 2-3 mau hola, ʻo 500-700 ng / ml a ma hope o 14-1 mau hola i hōʻemi ʻia e 50%. Hoʻopili piha ia e ka ʻōpio. ʻO ka hapa nui o ka metabolites ka mea i hoʻopili ʻia ma loko o ka bile a ma o nā mea pono ʻole. Hoʻokahi wale wale kahi hapa o nā metabolites i ka urine. ʻO ke ʻano o ka pākuʻi a me ke ʻano o ka hoʻokele ʻana, ma kahi o 5% (i loko o ke ʻano o nā metabolites) o ka nui o ka waihona lawelawe ʻia i loaʻa i loko o ka urine. ʻO ka pae o ka glurenorm excretion e nā keiki me ka liʻiliʻi ʻoi aku me ka hoʻohana maʻamau.

Nā Hōʻike
ʻO ka maʻi diabetes mellitus type 2 i nā mea maʻi waena a me nā meaʻelemakule (me ka loaʻa ʻole o ka mālama ʻana i nā lāʻau lapaʻau).

epersensitivity a sulfonylureas a sulfonamides,

maʻi diabetes type 1

maʻi maʻamau ketoacidosis, precoma, coma,

kūlana ma hope o ka haʻalele ʻana o ka pancreatic,

pphphia paʻa hepatic,

lima hana hoʻopili hewa,

kekahi mau maʻi kaulike (no ka laʻana, nā maʻi maʻi hopukia a i ʻole nā mea maʻi koʻikoʻi ke hōʻike ʻia kahi maʻi insulin),

hapai, ka manawa o nā umauma.

Me ka mālama pono
Hoʻohana ʻia ʻo Glurenorm no:

ʻiliʻala maʻi

mai nā maʻi thyroid (me ka hana ʻole o ke kanaka).

waiʻona.

ʻLelo ʻia a me ka wā o ka umauma
Hoʻopili ʻia ke hoʻohana ʻana o Glyurenorm i ka wā hāpai.
I ka hihia o ka hapai ʻana, pono ʻoe e kāpae i ka lawe ʻana i ka lāʻau lapaʻau a kūkā koke i kahi kauka.
Inā pono e hoʻohana i ka lāʻau lapaʻau i ka wā o ka hoʻoulu ʻana, pono ka pale umauma.

ʻ a me ke kākele
Hoʻohana ʻia ka lāʻau.
ʻO ke koho o ka huehoe a me ka regimen e lawe ʻia ma lalo o ka kaomi o ka pau aʻe o ka hōʻoli. ʻO ka maʻa mua o Glyurenorm ka mea maʻamau ma 14 mau papa (15 mg) i ka manawa kakahiaka. Inā pono, e hoʻonui i ka wīwī e like me ka ʻōlelo a ke kauka. ʻO ka hoʻonui ʻana i ka nui o nā pōpoki ma mua o 4 papa (120 mg) i kēlā me kēia lā maʻamau ʻaʻole alakaʻi i ka hoʻonui hou i ka hopena. Inā ʻaʻole nui ka make o ka lā o Glyurenorm i kēlā me kēia papa o 2 papa (60 mg), hiki ke kuhikuhi ʻia i hoʻokahi pākahi, i ka wā kakahiaka. Ke koho nei i kahi kiʻekiʻe kiʻekiʻe, hiki ke loaʻa ka hopena maikaʻi loa e ka lawe ʻana i kahi laʻina i kēlā me kēia lā i hoʻokaʻawale ʻia i 2-3 dosis. I kēia hihia, pono ke kiʻi ʻia ka papa kiʻekiʻe loa ma ka kakahiaka kakahiaka. E lawe ʻia ka Glurenorm me ka meaʻai, i ka hoʻomaka ʻana o kahi pāʻina.
Ke hoʻopili nei i kahi kuʻuna hypoglycemic waha me kahi hana like o ka hana ka hoʻoholo mua ʻia ʻana ma muli o ka papa o ka maʻi i ka manawa hoʻokele o ka lāʻau lapaʻau. ʻO ka maʻa mua ka maʻamau maʻamau 1/2 a 1 papa (15-30 mg).
Inā hāʻawi ʻole ʻo monotherapy i ka hopena i manaʻo ʻia, hiki i kahi koho hou o ka biguanide.

Mai ka palaki kuʻekuʻe:
Ma mua o 1%	uha, luaʻi, constipation, ʻeha, ʻeha hopohopo, intrahepatic cholestasis (1 hihia).
Dermatological:
0,1-1%	itching, eczema, urticaria (1 hihia), ʻo Stevens Johnson maʻi.
Mai ka ʻōnaehana hoʻonāukiuki:
0,1-1%	- headache, dizziness, disorientation.
Mai ka hematopoietic ʻōnaehana:
Na lalo o ka 0.1%	thrombocytopenia, leukopenia (1 hihia), agranulocytosis (1 hihia).

Ke keu
Hiki i nā kūlana hypoglycemic.
I ka hihia o ka hoʻolālāʻana o kahi kūlana hypoglycemic, pono koke ka hoʻomālamalama o ka glucose i loko a i ʻole intravenously.

ʻO ka pilina me nā lāʻau lapaʻau ʻē aʻe
ʻO ka salicylates, sulfonamides, phenylbutazone derivatives, anti-tuberculosis drug, chloramphenicol, tetracyclines and Coumarin derivatives, cyclophosphamides, MAO inhibitors, ACE inhibitors, clofibrate, β-adrenergic blocking agents, sympatholytics (clonidine), resericic (a) cleridine)
Hiki ke hoʻemi i ka hopena hypoglycemic aʻo ke kuhikuhi ʻana i ka Glurenorm a me nā sympathomimetics, glucocorticosteroids, heʻano thyroid, glucagon, thiazide diuretics, oral contraceptives, diazoxide, fenothiazine a me nā lāʻau lapaʻau e pili ana i ka acid nicotinic, barbiturates, rifampinin, fen. ʻO ka hoʻonui a hoʻohui ʻia paha o ka hopena i wehewehe ʻia me H₂-a laka (cimetidine, ranitidine) a me nā waiʻona.

Nā ʻōlelo kikoʻī
Pono e hahai pono i nā loiloi a ke kauka e kuhikuhi ana i ka hoʻoponopono ʻana i nā pakano kalepa i ka mea maʻi. Mai ho'ōki i ka mālama ʻana iā ʻoe iho me ka ʻole o ka hoʻolaha ʻana i kāu kauka. ʻOiai glurenorm e hoʻokaʻawale iki ʻia i loko o ka urine (5%) a ke hoʻokaʻawale pinepine ʻia nei i nā poʻe maʻi me ka maʻi ʻeha, mālama ʻia nā mea maʻi me ka hōʻeha o ke aʻalolo kahi mea e pono ai e mālama ma lalo o ka mālama mālama olakino.
ʻO ka maʻi me ka diabetes mellitus e loaʻa i ka hoʻolālā ʻana o nā maʻi cardiovascular, hiki ke hōʻemi ʻia kahi mea hoʻopiʻi wale nō me ka paʻa ʻole i ka meaʻai i kuhikuhi ʻia. ʻAʻole pono ke kuʻuna hypoglycemic oral i ke olakino e hiki ai iā ʻoe ke kāohi i ka kaumaha o ke kino o ka mea maʻi. ʻO nā ʻaihue hypoglycemic waha āpau me ka ʻai ʻole o ka meaʻai a i ʻole hoʻokō ʻole ʻia me ka hoʻoponopono regimen i ʻōlelo ʻia i hiki ke piʻi i nā nui o ka pae ʻana o ke kō o ke koko a me ka hoʻomohala ʻana o kahi kūlana hypoglycemic. ʻO ka inu ʻana i ke kō, nā mea ʻala, a me nā mea momona ʻaʻa e kōkua pono e pale i kahi ʻano hypoglycemic hoʻomaka. I ka hihia o ka mokuahi hypoglycemic, pono koke ʻoe e ʻōlelo aku i ke kauka.
Inā manaʻo ʻoe ʻole ka maʻi (ʻū, ʻū, nausea) i ka wā o ka mālama ʻana me Glurenorm, pono koke ʻoe e ʻōlelo aku i kekahi kauka.
Inā ulu nā hopena kūlohelohe, pono ʻoe e kāpae i ka lawe ʻana iā Glyurenorm, ke hoʻololi nei iā ia me kekahi lāʻau lapaʻau hypoglycemic a i ʻole insulin.

Hoʻokomo i ka hiki ke lawe i nā kaʻa a kāohi i nā mīkini
I ka wā o ke koho ʻana i kahi momona a i ʻole ka loli i ka lāʻau lapaʻau, pono ʻoe e pale i ka hana ʻana i nā hana e pili ana i ka mea e pono ai ka nānā nui a me ka wikiwiki o ka hopena psychomotor.

E hoʻokuʻu i ke ʻano
30 mg papa
Ma nā papa 10 i kahi pōpō palula palula (blister) mai PVC / Al.
No nā lālani 3, 6 a 12 paha, me nā kauoha no ka hoʻohana ʻana i kahi pahu kāleka.

Nā kūlana mālama
I kahi wahi maloʻo, ma kahi mahana ʻaʻole iʻoi aku ma mua o 25 ° C.
E mālama i kahi hiki ʻana i nā keiki!

ʻO ka lā kau
5 mau makahiki
Mai hoʻohana ma hope o ka lā pau pau i hōʻike ʻia ma ka pahu.

ʻO nā lā hoʻomaha mai nā hale kūʻai
Ma ke kumu.

Mea hana
Beringer Ingelheim Ellas A.E., Greece Helene, 19003 Kings Avenue Pkanias Markopoulou, 5th km

Nā Hōʻike ma Moscow:
119049, Moscow, st. Donskaya 29/9, kūkulu hale 1.